PE20090680A1 - Pulverizacion de hormonas transdermicas - Google Patents

Pulverizacion de hormonas transdermicas

Info

Publication number
PE20090680A1
PE20090680A1 PE2008001594A PE2008001594A PE20090680A1 PE 20090680 A1 PE20090680 A1 PE 20090680A1 PE 2008001594 A PE2008001594 A PE 2008001594A PE 2008001594 A PE2008001594 A PE 2008001594A PE 20090680 A1 PE20090680 A1 PE 20090680A1
Authority
PE
Peru
Prior art keywords
transdermal
estrogens
hormone therapy
composition
spraying
Prior art date
Application number
PE2008001594A
Other languages
English (en)
Inventor
R Saul Levinson
Larry G Miller
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of PE20090680A1 publication Critical patent/PE20090680A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Abstract

SE REFIERE A UNA COMPOSICION DE PULVERIZACION TRANSDERMICA DE ESTROGENOS QUE CONTIENE: A) UN ESTROGENO TAL COMO ESTRADIOL B) UN POTENCIADOR DE LA PENETRACION TALES COMO 2-FENOXIETANOL, TIMOL, CINEOL, TERPENOIDES, PIRROLIDONAS, AZONAS, ENTRE OTROS; C) UN DISOLVENTE VOLATIL TAL COMO ETANOL E ISOPROPANOL. DICHA COMPOSICION ES DE ADMINISTRACION DERMICA DONDE EL FLUJO TRANSDERMICO EN VIVO DE ESTROGENOS ES DE 0.03 A 0.3 ug/cm2 POR HORA. SIENDO UNA COMBINACION UTIL EN EL TERAPIA HORMONAL MASCULINA CON DEFICIENCIA DE TESTOSTERONA, TERAPIA HORMONAL FEMENINA POSTMENOPAUSICAS, ENTRE OTROS
PE2008001594A 2007-09-14 2008-09-12 Pulverizacion de hormonas transdermicas PE20090680A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99375507P 2007-09-14 2007-09-14

Publications (1)

Publication Number Publication Date
PE20090680A1 true PE20090680A1 (es) 2009-06-19

Family

ID=40452546

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001594A PE20090680A1 (es) 2007-09-14 2008-09-12 Pulverizacion de hormonas transdermicas

Country Status (6)

Country Link
US (1) US20090075963A1 (es)
AR (1) AR068408A1 (es)
CA (1) CA2699632A1 (es)
CL (1) CL2008002721A1 (es)
PE (1) PE20090680A1 (es)
WO (1) WO2009036355A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110094858A (ko) * 2010-02-18 2011-08-24 에스케이케미칼주식회사 피부 자극이 감소한 톨테로딘의 경피 투여용 조성물
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
US9144553B2 (en) * 2012-12-21 2015-09-29 Teikoku Pharma Usa, Inc. Compositions and methods for transdermal delivery of hormones and other medicinal agents
WO2019140087A1 (en) 2018-01-10 2019-07-18 Celista Pharmaceuticals Llc Testosterone transdermal spray with film

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
US5304368A (en) * 1993-02-19 1994-04-19 American Telecast Corporation Non-foaming, non-viscous, alcohol-free, water-based, pressurized hair spray product
US5624060A (en) * 1995-05-02 1997-04-29 Ellion; M. Edmund Invertible dispensing system and dip tube
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6923983B2 (en) * 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6998138B2 (en) * 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6929801B2 (en) * 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
FR2758479B1 (fr) * 1997-01-20 1999-03-26 Valois Dispositif pour distribuer un produit fluide ou pulverulent a une distance predeterminee
US5912240A (en) * 1997-04-10 1999-06-15 Loria; Roger M. 5-androstene 3β, 17α diol as an inhibitor of tumor growth
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
US6113008A (en) * 1998-08-20 2000-09-05 3M Innovative Properties Company Actuator system for spraying a formulation onto a host
AU2001282064B2 (en) * 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
AUPR184500A0 (en) * 2000-12-01 2001-01-04 Drug Delivery Solutions Pty Ltd Dispensing device
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
KR20050045946A (ko) * 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
US20050186141A1 (en) * 2002-06-25 2005-08-25 Acrux Dds Pty Ltd. Transdermal aerosol compositions
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
PT1670433E (pt) * 2003-10-10 2012-02-08 Ferring Bv Fórmula farmacológica transdérmica para a minimização de resíduos na pele
CN1886171A (zh) * 2003-11-28 2006-12-27 艾克若克斯Dds有限公司 快速经皮施用的方法和系统
EP1703938A1 (en) * 2003-12-10 2006-09-27 Acrux DDS Pty Ltd Method of treatment for undesired effect following transdermal or topical drug delivery
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
DK2219603T3 (da) * 2007-11-02 2014-09-01 Acrux Dds Pty Ltd Transdermalt afgivelsessystem

Also Published As

Publication number Publication date
CA2699632A1 (en) 2009-03-19
CL2008002721A1 (es) 2008-12-19
AR068408A1 (es) 2009-11-18
US20090075963A1 (en) 2009-03-19
WO2009036355A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
AR056453A1 (es) Composiciones con estrogeno y metodos terapeuticos para su uso
PE20090680A1 (es) Pulverizacion de hormonas transdermicas
PE20140925A1 (es) Composicion farmaceutica que comprende un precursor de esteroides sexuales
MX2016013693A (es) Crema transdermica.
MX2018011706A (es) Composicion farmaceutica de hormona esteroide.
SV2009003231A (es) Uso de valerato de estradiol o 17b-estradiol en combinacion con dienogest en una terapia oral para mantener y/o implementar la libido femenina
WO2008049516A3 (de) Transdermales therapeutisches system enthaltend norelgestromin zur kontrazeption und hormonsubstitution
HN2008000621A (es) Metodo para la anticopcepcion hormonal preventiva bajo demanda
NZ586759A (en) Aqueous-alcoholic, single-phase transcutaneous pharmaceutical compositions containing a steroid hormone
CA2674078A1 (en) Topical administration of danazol
RS20060348A (en) Extended use combination comprising estrogens and progestins
ATE330614T1 (de) Topisch anzuwendende östrogen/progestin enthaltende arzneimittel mit systemischer wirkung
MX2014015898A (es) Formulaciones y terapias de reemplazo de combinacion de hormonas naturales.
CL2011003172A1 (es) Composicion farmaceutica que comprende a) un excepiente, b) al menos un precursor de esteroides sexuales, c) al menos un modulador selectivo del receptor de estrogenos o una antiestrogeno y no contiene una progestina y/o un estrogeno; kit farmaceutico; y uso para reducir o eliminar sofocos, sintomas vasomotores y sudores nocturnos.
CR7022A (es) Productos esteroides hormonales y metodos para su preparacion
CL2011001017A1 (es) Composicion farmaceutica acuosa que no provoca ardor ni irritacion, que comprende un ingrediente anestesico de accion topica, un alcanol inferior, un agente reforzador de la penetracion molecular y un portador; su uso para aliviar el dolor asociado con herpes zoster.
PE20140936A1 (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
WO2007092284A3 (en) Low dose no donor-containing transdermal patch
PE20070188A1 (es) Formulaciones de estrogenos conjugados y bazedoxifeno
CR10289A (es) "estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva"(divisional)
PE20090625A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
GT200400262A (es) Hormonas de administracion transdermica que no necesitan potenciadores de penetracion.
PE20190707A1 (es) Formulaciones de buprenorfina de liberacion sostenida
HN2010000081A (es) Estratrienos 8-beta-sustituidos como estrogenos de accion selectiva
WO2018224736A3 (en) THERAPEUTICALLY ACTIVE STEROID DERIVATIVES

Legal Events

Date Code Title Description
FD Application declared void or lapsed